The strong relationship between disease severity and thiol-disulphide homeostasis in patients with restless legs syndrome
暂无分享,去创建一个
O. Erel | S. Neşelioğlu | E. Yurt | S. Erdogan | E. Dirik | Y. Eren | O. Deniz
[1] S. Steffensen,et al. Peripheral Dopamine in Restless Legs Syndrome , 2018, Front. Neurol..
[2] Ö. Erel,et al. Thiol/disulphide homeostasis in schizophrenia patients with positive symptoms , 2018, Nordic journal of psychiatry.
[3] A. Hartzema,et al. Adherence and persistence to ropinirole, pramipexole, and gabapentin in patients with newly diagnosed restless legs syndrome. , 2017, Sleep medicine.
[4] O. Erel,et al. Impairment of dynamic thiol–disulphide homeostasis in patients with idiopathic Parkinson’s disease and its relationship with clinical stage of disease , 2017, Clinical Neurology and Neurosurgery.
[5] A. Walters,et al. Restless Legs Syndrome: Current Concepts about Disease Pathophysiology , 2016, Tremor and other hyperkinetic movements.
[6] O. Erel,et al. Evaluation of thiol levels, thiol/disulfide homeostasis and their relation with inflammation in cardiac syndrome X , 2016, Coronary artery disease.
[7] O. Erel,et al. The relation of serum thiol levels and thiol/disulphide homeostasis with the severity of coronary artery disease. , 2016, Kardiologia polska.
[8] O. Erel,et al. A novel oxidative stress marker in migraine patients: dynamic thiol–disulphide homeostasis , 2016, Neurological Sciences.
[9] O. Erel,et al. A novel oxidative stress marker in patients with Alzheimer’s disease: dynamic thiol–disulphide homeostasis , 2016, Acta Neuropsychiatrica.
[10] O. Erel,et al. Comparison of thiol/disulphide homeostasis parameters in patients with COPD, asthma and ACOS. , 2016, European review for medical and pharmacological sciences.
[11] O. Erel,et al. Association of thiol disulfide homeostasis with slow coronary flow , 2016, Scandinavian cardiovascular journal : SCJ.
[12] M. Abe,et al. Association of restless legs syndrome with oxidative stress and inflammation in patients undergoing hemodialysis. , 2015, Sleep medicine.
[13] O. Erel,et al. Dynamic thiol-disulfide homeostasis in hyperemesis gravidarum , 2015, Journal of Perinatology.
[14] O. Erel,et al. A novel and automated assay for thiol/disulphide homeostasis. , 2014, Clinical biochemistry.
[15] Richard P Allen,et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. , 2014, Sleep medicine.
[16] Y. Türker,et al. Association between restless leg syndrom and slow coronary flow. , 2014, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology.
[17] Rafael Radi,et al. The thiol pool in human plasma: the central contribution of albumin to redox processes. , 2013, Free radical biology & medicine.
[18] G. Baskol,et al. Assessment of nitric oxide, advanced oxidation protein products, malondialdehyde, and thiol levels in patients with restless legs syndrome. , 2012, Sleep medicine.
[19] J. Sztajzel,et al. Oxidative stress and autonomic nervous system functions in restless legs syndrome , 2011, European journal of clinical investigation.
[20] J. Mieyal,et al. Levodopa deactivates enzymes that regulate thiol-disulfide homeostasis and promotes neuronal cell death: implications for therapy of Parkinson's disease. , 2010, Biochemistry.
[21] D. Dean,et al. Structure, function, and formation of biological iron-sulfur clusters. , 2005, Annual review of biochemistry.
[22] M. Piercey,et al. Pramipexole — a new dopamine agonist for the treatment of Parkinson's disease , 1999, Journal of the Neurological Sciences.
[23] C. Peschle,et al. Oxidative stress leads to a rapid alteration of transferrin receptor intravesicular trafficking. , 1998, Experimental cell research.
[24] A. Camerman,et al. Stereochemistry of dopaminergic ergoline derivatives: structures of pergolide and pergolide mesylate , 1987 .
[25] L. Akpinar. Restless Legs Syndrome Treatment with Dopaminergic Drugs , 1987, Clinical neuropharmacology.
[26] N. Chasteen. The identification of the probable locus of iron and anion binding in the transferrins , 1983 .
[27] J. Connor,et al. Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report. , 2018, Sleep medicine.
[28] W. Oertel,et al. Restless legs syndrome in Parkinson's disease and other neurodegenerative diseases of the central nervous system , 2007, Movement disorders : official journal of the Movement Disorder Society.
[29] J. Kehr,et al. Determination of the dopamine agonist rotigotine in microdialysates from the rat brain by microbore column liquid chromatography with electrochemical detection. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[30] R. Crichton. Structure and function of ferritin. , 1973, Angewandte Chemie.